Puma Biotechnology | PBYI - إيرادات الفوائد





إيرادات الفوائد تغيير تاريخ
Agios Pharmaceuticals USD 12.41M 959K 2025-12
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 19.21M 1.36M 2025-12
Daiichi Sankyo JPY 9.96B 230M 2024-03
Esperion Therapeutics USD -0.15 0.18 2024-09
Exelixis USD 17.43M 1.5M 2025-12
Gilead Sciences USD 95M 7M 2025-12
Glaxosmithkline GBP 26M 24M 2025-09
Incyte USD 33.69M 2.93M 2026-03
MacroGenics USD 1.53M 114K 2025-09
Moderna USD 70M 3M 2025-12
Pfizer USD 166M 166M 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Takeda JPY 87.87B 43.48B 2025-12
Ultragenyx Pharmaceutical USD 6.51M 649K 2025-12
Vertex Pharmaceuticals USD 121.9M 3.8M 2025-12